Nanoviricides (NNVC) Notes Payables (2011 - 2023)
Nanoviricides (NNVC) posted Notes Payables of $243881.0 for Q1 2023, down 34.69% sequentially from $373424.0 in Q4 2022, and up 231.42% YoY from $73587.0 in Q1 2022.
Nanoviricides (NNVC) Notes Payables (2011 - 2023) Analysis & Trends
Nanoviricides has reported Notes Payables for 13 years, with the latest figure at $243881.0 in Q1 2023.
- Quarterly Notes Payables rose 231.42% year-over-year to $243881.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $243881.0 (up 231.42% YoY) and the FY2022 annual result came in at $214397.0, up 579.78% from the prior year.
- Notes Payables slipped to $243881.0 in Q1 2023 per NNVC's latest filing, from $373424.0 in the prior quarter.
- Over five years, Notes Payables peaked at $1.1 million in Q3 2020 and troughed at $31539.0 in Q2 2021.
- A 5-year average of $517508.9 and a median of $497349.5 in 2020 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2019 and 2021: Notes Payables surged 666.54% in 2019, then tumbled 94.38% in 2021.
- Over 5 years, Notes Payables stood at $1.1 million in 2019, then plunged by 87.87% to $128904.0 in 2020, then rose by 29.51% to $166948.0 in 2021, then jumped by 123.68% to $373424.0 in 2022, then tumbled by 34.69% to $243881.0 in 2023.
- According to Business Quant data, Notes Payables over the past three periods registered $243881.0, $373424.0, and $433119.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Nanoviricides | 28.74 Mn | 25.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 243,881.00 |
| Dec 31, 2022 | 373,424.00 |
| Sep 30, 2022 | 433,119.00 |
| Jun 30, 2022 | 214,397.00 |
| Mar 31, 2022 | 73,587.00 |
| Dec 31, 2021 | 166,948.00 |
| Sep 30, 2021 | 705,177.00 |
| Jun 30, 2021 | 31,539.00 |
| Mar 31, 2021 | 583,075.00 |
| Dec 31, 2020 | 128,904.00 |
| Sep 30, 2020 | 1.09 Mn |
| Jun 30, 2020 | 561,580.00 |
| Mar 31, 2020 | 1.07 Mn |
| Dec 31, 2019 | 1.06 Mn |
| Sep 30, 2019 | 714,417.00 |
| Jun 30, 2019 | 823,783.00 |
| Dec 31, 2018 | 800,830.00 |
| Sep 30, 2018 | 718,457.00 |
| Jun 30, 2018 | 107,468.00 |
| Mar 31, 2018 | 902,426.00 |